• Save

New Prohibited Substance Case under FEI Anti-Doping Rules

Lausanne (SUI), 22 December 2016 – The FEI has announced an adverse analytical finding involving a prohibited substance.

Samples taken at the CSI 4* at Coapexpan (MEX) on 14 October 2016 from the horse La Petite Fleur 6 (FEI ID 103TN40/MEX), ridden by Andres Arozarena (FEI ID 10094207/MEX) to finish as runner-up in the speed class on the second day of the event, have returned positive for Piroxicam.

Piroxicam, a non-steroidal anti-inflammatory drug used for the treatment of rheumatic disorders, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

The athlete has been provisionally suspended from the date of notification (20 December 2016). The horse has also been suspended for a two-month period.

Further details on this case can be found here.

The FEI’s Prohibited Substances List is divided into two sections – Controlled Medication and Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) substances should never be found in the body of the horse.

FEI Media contacts:

Grania Willis
Director Press Relations
grania.willis@fei.org
+41 787 506 142

Leanne Williams
Manager Press Relations
leanne.williams@fei.org
+41 79 314 24 38

Leave a Reply